Intravitreal Aflibercept Injection for Radiation Retinopathy Trial

NCT03085784 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Radiation Retinopathy

Interventions

DRUG: Aflibercept

Sponsor

Amy C Schefler, MD

Collaborators

[object Object]